Lercanidipine



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 44.4%
Prophylaxis Against Transplant Rejection 11.1%
Cardiac Failure 8.3%
Hyperuricaemia 5.6%
Type 2 Diabetes Mellitus 5.6%
Antiviral Prophylaxis 2.8%
Atrial Fibrillation 2.8%
Depression 2.8%
Diabetes Mellitus 2.8%
Erysipelas 2.8%
Gastritis 2.8%
Gout 2.8%
Hypothyroidism 2.8%
Product Used For Unknown Indication 2.8%
Agitation 14.3%
Erythema 14.3%
Leukocytoclastic Vasculitis 14.3%
Myopathy 14.3%
Overdose 14.3%
Tremor 14.3%
Vomiting 14.3%
Secondary
Hypertension 31.4%
Product Used For Unknown Indication 28.2%
Drug Use For Unknown Indication 8.0%
Type 2 Diabetes Mellitus 5.5%
Essential Hypertension 3.6%
Atrial Fibrillation 3.5%
Myocardial Ischaemia 2.9%
Diabetes Mellitus 2.5%
Breast Cancer 2.3%
Thrombosis Prophylaxis 1.6%
Upper Respiratory Tract Infection 1.5%
Blood Pressure 1.4%
Ear Infection 1.4%
Depression 1.1%
Arrhythmia 1.0%
Blood Cholesterol Increased 0.9%
Bronchopneumonia 0.9%
Epilepsy 0.8%
Cardiovascular Event Prophylaxis 0.7%
Gout 0.7%
Hyponatraemia 10.8%
Renal Failure Acute 10.0%
Vomiting 9.2%
Oedema Peripheral 8.3%
Hypoglycaemia 5.0%
Loss Of Consciousness 5.0%
Throat Irritation 5.0%
Liver Function Test Abnormal 4.2%
Orthostatic Hypotension 4.2%
Sudden Death 4.2%
Toxic Skin Eruption 4.2%
Cytolytic Hepatitis 3.3%
Dehydration 3.3%
Dyspnoea 3.3%
Hypotension 3.3%
Ischaemic Stroke 3.3%
Leukocytoclastic Vasculitis 3.3%
Myocardial Infarction 3.3%
Nocturia 3.3%
Pancreatitis Acute 3.3%
Concomitant
Product Used For Unknown Indication 31.2%
Hypertension 25.5%
Drug Use For Unknown Indication 11.7%
Type 2 Diabetes Mellitus 3.3%
Atrial Fibrillation 3.2%
Diabetes Mellitus 3.1%
Prophylaxis 2.8%
Rheumatoid Arthritis 2.3%
Osteoporosis 1.9%
Hepatitis C 1.7%
Depression 1.6%
Coronary Artery Disease 1.6%
Hypercholesterolaemia 1.5%
Pain 1.5%
Chronic Obstructive Pulmonary Disease 1.4%
Multiple Myeloma 1.3%
Renal Transplant 1.3%
Non-small Cell Lung Cancer 1.2%
Thrombosis Prophylaxis 1.1%
Hiv Infection 1.0%
Renal Failure Acute 11.6%
Vomiting 8.9%
Weight Decreased 6.4%
Renal Impairment 6.1%
Death 5.5%
Renal Failure 5.5%
Palpitations 4.9%
Pyrexia 4.6%
Diarrhoea 4.3%
Pulmonary Embolism 4.3%
Thrombocytopenia 4.3%
Cerebrovascular Accident 4.0%
Drug Interaction 4.0%
Dyspnoea 3.7%
Hypertension 3.7%
International Normalised Ratio Increased 3.7%
Liver Function Test Abnormal 3.7%
Rash 3.7%
Sepsis 3.7%
White Blood Cell Count Increased 3.7%
Interacting
Product Used For Unknown Indication 65.6%
Hypertension 13.2%
Lower Respiratory Tract Infection 5.2%
Supraventricular Tachycardia 5.2%
Hiv Infection 2.8%
Diabetes Mellitus 1.9%
Restlessness 1.4%
Back Pain 0.9%
Benign Prostatic Hyperplasia 0.9%
Peripheral Arterial Occlusive Disease 0.9%
Blood Cholesterol Increased 0.5%
Hypothyroidism 0.5%
Ischaemic Heart Disease Prophylaxis 0.5%
Trigeminal Neuralgia 0.5%
Hypotension 28.6%
Atrial Fibrillation 21.4%
Drug Interaction 10.7%
Dizziness 7.1%
Hypoglycaemia 7.1%
Tachycardia 7.1%
Ventricular Extrasystoles 7.1%
Product Quality Issue 3.6%
Syncope 3.6%
Trigeminal Neuralgia 3.6%